EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
37 hedge funds and large institutions have $90.4M invested in Eucrates Biomedical Acquisition Corp. Unit in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$10.7M |
| 2 |
BlackRock
New York
|
+$9.86M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.17M |
| 4 |
6CM
683 Capital Management
New York
|
+$6.4M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$5.33M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Jane Street
New York
| $853K | +$853K | +80,000 | New |
|
|
BFM
27
Boothbay Fund Management
New York
| $752K | +$752K | +70,571 | New |
|
|
MS
28
Maven Securities
St Helier,
Jersey
| $533K | +$533K | +50,000 | New |
|
29
TD Asset Management
Toronto,
Ontario, Canada
| $459K | +$459K | +43,657 | New |
|
|
PAM
30
Panagora Asset Management
Boston,
Massachusetts
| $124K | +$124K | +11,951 | New |
|
|
HF
31
HRT Financial
New York
| $121K | +$121K | +11,385 | New |
|
|
EAM
32
Exos Asset Management
New York
| $112K | +$112K | +10,486 | New |
|
|
LCM
33
Landscape Capital Management
Englewood,
New Jersey
| $107K | +$107K | +10,000 | New |
|
|
WAM
34
Wolverine Asset Management
Chicago,
Illinois
| $35K | +$35K | +3,360 | New |
|
35
UBS Group
Zurich,
Switzerland
| $19K | +$19K | +1,748 | New |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | +$11K | +1,000 | New |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| $1K | +$1K | +96 | New |
|